Home

Atlas Venture Fund VI GmbH & Co KG

CIK 1292358 · last filed 2012-03-06

Atlas Venture Fund VI GmbH & Co KG is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing shows the insider bought $12.0M of HZNP on Mar 6, 2012. Across all open-market trades the lifetime net is +$12.0M, making them a net buyer over the disclosed history. The firm reports its address in Waltham, MA. 20 SEC filings were submitted jointly with ATLAS VENTURE ENTREPRENEURS FUND VI LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$12.00M

Filer Profile

Reported Address
890 WINTER STREET
SUITE 320
WALTHAM, MA 02451
Phone
(781) 622-1700
Related Filers
ATLAS VENTURE ENTREPRENEURS FUND VI LP — 20 joint filings, latest 2018-05-10
ATLAS VENTURE FUND VI LP — 20 joint filings, latest 2018-05-10
ATLAS VENTURE ASSOCIATES V LP — 15 joint filings, latest 2009-09-22
ATLAS VENTURE ENTREPRENEURS FUND V LP — 15 joint filings, latest 2009-09-22
ATLAS VENTURE FUND V LP — 15 joint filings, latest 2009-09-22
ATLAS VENTURE PARALLEL FUND V-A C V — 13 joint filings, latest 2007-05-31
ALNYLAM PHARMACEUTICALS, INC. — 6 joint filings, latest 2006-02-27
Atlas Venture Associates VII, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Horizon Therapeutics Public Ltd Co (HZNP) Delisted 10%+ Owner 3,688,294 $116.30 $428.95M $12.00M 1 2012-03-06

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-03-06 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Buy (P) +3,313,772 $12.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.